← back to search

R. Duncan Hite

University of California System · US
Area of research
Pulmonary and Respiratory Medicine · Epidemiology
Research interest
Research interests include Medicine, Randomized controlled trial, Sepsis, Placebo, ARDS, and Organ dysfunction.
h-index
citations
2,056
works
12
NIH funding
primary concept
email

Recent publications

Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis
JAMA 2024cited by 33position: middledoi
Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial
The Lancet Respiratory Medicine 2024cited by 18position: middledoi
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
JAMA 2023cited by 97position: middledoi
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
UCL Discovery (University College London) 2022cited by 192position: middle
Biological Effects of Intravenous Vitamin C on Neutrophil Extracellular Traps and the Endothelial Glycocalyx in Patients with Sepsis-Induced ARDS
Nutrients 2022cited by 37position: middledoi
Enabling a learning healthcare system with automated computer protocols that produce replicable and personalized clinician actions
Journal of the American Medical Informatics Association 2020cited by 39position: middledoi
Three Alveolar Phenotypes Govern Lung Function in Murine Ventilator-Induced Lung Injury
Frontiers in Physiology 2020cited by 30position: middledoi
Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure
JAMA 2019cited by 820position: middledoi
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness
New England Journal of Medicine 2018cited by 567position: middledoi
Critical Care Organizations: Building and Integrating Academic Programs
Critical Care Medicine 2017cited by 32position: middledoi
Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome
Annals of the American Thoracic Society 2016cited by 62position: middledoi
Fluid Management With a Simplified Conservative Protocol for the Acute Respiratory Distress Syndrome*
Critical Care Medicine 2014cited by 129position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kathleen D. Liu · University of California San Francisco Medical Center2 papers (2014–2016)Derek C. Angus · Syngenta (United Kingdom)2 papers (2016–2017)Catherine L. Hough · Durham VA Medical Center1 papers (2016–2016)Alyx Cleveland · University of Vermont1 papers (2020–2020)Michelle N. Gong · Hospital Civil de Guadalajara1 papers (2016–2016)Lars Knudsen · Medizinische Hochschule Hannover1 papers (2020–2020)Michael J. Lanspa · Intermountain Healthcare1 papers (2014–2014)David T. Huang · University of Rochester Medical Center1 papers (2016–2016) · 1 papers (2017–2017)Alpha A. Fowler · National Heart Lung and Blood Institute1 papers (2022–2022)Samuel M. Brown · Jisc1 papers (2014–2014)Jonathon D. Truwit · Medical College of Wisconsin1 papers (2022–2022)Bernard Fisher · NSABP Foundation1 papers (2022–2022)John W. Christman · University of Illinois Chicago1 papers (2017–2017)Peter C. Hou · Harvard University1 papers (2016–2016)Daniel Talmor · Harvard University1 papers (2016–2016)Bradford J. Smith · University of Colorado System1 papers (2020–2020)Michael Novotny · Cleveland Clinic Lerner College of Medicine1 papers (2020–2020)M. L'Heureux · Virginia Commonwealth University1 papers (2022–2022)Kayo Okamura · University of Colorado Denver1 papers (2020–2020)